vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and WESCO INTERNATIONAL INC (WCC). Click either name above to swap in a different company.
WESCO INTERNATIONAL INC is the larger business by last-quarter revenue ($6.1B vs $5.5B, roughly 1.1× Fresenius Medical Care AG). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 2.6%, a 5.3% gap on every dollar of revenue. On growth, WESCO INTERNATIONAL INC posted the faster year-over-year revenue change (10.3% vs -0.3%).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Wesco International, Inc. is a publicly traded American holding company for Wesco Distribution, an electrical distribution and services company based in Pittsburgh, Pennsylvania.
FMS vs WCC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $6.1B |
| Net Profit | $434.2M | $159.8M |
| Gross Margin | 27.4% | 21.2% |
| Operating Margin | 11.7% | 5.3% |
| Net Margin | 7.9% | 2.6% |
| Revenue YoY | -0.3% | 10.3% |
| Net Profit YoY | 240.4% | -3.4% |
| EPS (diluted) | — | $3.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | $6.1B | ||
| Q3 25 | — | $6.2B | ||
| Q2 25 | — | $5.9B | ||
| Q1 25 | — | $5.3B | ||
| Q4 24 | $5.5B | $5.5B | ||
| Q3 24 | — | $5.5B | ||
| Q2 24 | — | $5.5B | ||
| Q1 24 | — | $5.3B |
| Q4 25 | $434.2M | $159.8M | ||
| Q3 25 | — | $187.5M | ||
| Q2 25 | — | $174.5M | ||
| Q1 25 | — | $118.4M | ||
| Q4 24 | $127.6M | $165.4M | ||
| Q3 24 | — | $204.3M | ||
| Q2 24 | — | $232.1M | ||
| Q1 24 | — | $115.8M |
| Q4 25 | 27.4% | 21.2% | ||
| Q3 25 | — | 21.3% | ||
| Q2 25 | — | 21.1% | ||
| Q1 25 | — | 21.1% | ||
| Q4 24 | 25.0% | 21.2% | ||
| Q3 24 | — | 22.1% | ||
| Q2 24 | — | 21.9% | ||
| Q1 24 | — | 21.3% |
| Q4 25 | 11.7% | 5.3% | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | 5.1% | 5.5% | ||
| Q3 24 | — | 6.1% | ||
| Q2 24 | — | 5.9% | ||
| Q1 24 | — | 4.9% |
| Q4 25 | 7.9% | 2.6% | ||
| Q3 25 | — | 3.0% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | 2.3% | 3.0% | ||
| Q3 24 | — | 3.7% | ||
| Q2 24 | — | 4.2% | ||
| Q1 24 | — | 2.2% |
| Q4 25 | — | $3.33 | ||
| Q3 25 | — | $3.79 | ||
| Q2 25 | — | $3.83 | ||
| Q1 25 | — | $2.10 | ||
| Q4 24 | — | $3.01 | ||
| Q3 24 | — | $3.81 | ||
| Q2 24 | — | $4.28 | ||
| Q1 24 | — | $1.95 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.4B | $5.0B |
| Total Assets | $33.5B | $16.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $15.4B | $5.0B | ||
| Q3 25 | — | $4.8B | ||
| Q2 25 | — | $4.8B | ||
| Q1 25 | — | $5.0B | ||
| Q4 24 | $17.0B | $5.0B | ||
| Q3 24 | — | $5.0B | ||
| Q2 24 | — | $4.9B | ||
| Q1 24 | — | $5.0B |
| Q4 25 | $33.5B | $16.5B | ||
| Q3 25 | — | $16.6B | ||
| Q2 25 | — | $16.2B | ||
| Q1 25 | — | $15.5B | ||
| Q4 24 | $36.3B | $15.1B | ||
| Q3 24 | — | $15.3B | ||
| Q2 24 | — | $15.1B | ||
| Q1 24 | — | $15.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | $71.9M |
| Free Cash FlowOCF − Capex | — | $27.5M |
| FCF MarginFCF / Revenue | — | 0.5% |
| Capex IntensityCapex / Revenue | — | 0.7% |
| Cash ConversionOCF / Net Profit | 6.67× | 0.45× |
| TTM Free Cash FlowTrailing 4 quarters | — | $25.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | $71.9M | ||
| Q3 25 | — | $-82.7M | ||
| Q2 25 | — | $107.8M | ||
| Q1 25 | — | $28.0M | ||
| Q4 24 | $2.6B | $276.6M | ||
| Q3 24 | — | $302.1M | ||
| Q2 24 | — | $-223.8M | ||
| Q1 24 | — | $746.3M |
| Q4 25 | — | $27.5M | ||
| Q3 25 | — | $-95.9M | ||
| Q2 25 | — | $86.0M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | — | $252.3M | ||
| Q3 24 | — | $272.9M | ||
| Q2 24 | — | $-244.6M | ||
| Q1 24 | — | $725.9M |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | -1.5% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | — | 5.0% | ||
| Q2 24 | — | -4.5% | ||
| Q1 24 | — | 13.6% |
| Q4 25 | — | 0.7% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.4% |
| Q4 25 | 6.67× | 0.45× | ||
| Q3 25 | — | -0.44× | ||
| Q2 25 | — | 0.62× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | 20.20× | 1.67× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | — | -0.96× | ||
| Q1 24 | — | 6.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FMS
Segment breakdown not available.
WCC
| CSS | $2.4B | 40% |
| EES | $2.3B | 37% |
| UBS | $1.4B | 23% |
